India, June 3 -- TG Therapeutics, Inc. (TGTX) shares rose 10.48 percent, gaining $3.84 to $40.48 on Tuesday after the company reported positive pharmacokinetic, pharmacodynamic, safety, and tolerabili... Read More
India, June 3 -- The Energy Information Administration released a report on Wednesday showing a significant decrease in U.S. crude oil inventories in the week ended May 29th. The report said crude oi... Read More
India, June 3 -- The Institute for Supply Management released a report on Wednesday showing its reading on U.S. service sector activity increased by more than expected in the month of May. The ISM sa... Read More
India, June 3 -- AIM ImmunoTech Inc. (AIM), an immune pharma company, announced the final enrolment of subjects in the Phase 2 clinical trial dubbed DURIPANC, evaluating AIM's drug Ampligen (rintatoli... Read More
India, June 3 -- Today's gainers list includes ABIVAX, which recently announced positive ulcerative colitis trial results; Cingulate, which is working toward resubmission of a New Drug Application for... Read More
India, June 3 -- Destination XL Group, Inc. (DXLG) reported loss for the first quarter on Wednesday, wider than the prior year loss, as sales at the Big + Tall menswear retailer fell. On the Nasdaq, ... Read More
India, June 3 -- A report released by payroll processor ADP on Wednesday showed private sector employment in the U.S. jumped by slightly more than expected in the month of May. ADP said private emplo... Read More
India, June 3 -- On Wednesday, Mutares SE & Co. KGaA (MUX.F), a private equity firm, announced that it signed an agreement to acquire TREPEL Airport Equipment GmbH and MAFI Transport-Systeme GmbH from... Read More
India, June 3 -- Ahead of Wednesday's holiday for Queen Suthida's birthday, the Thai stock market had ended the two-day slide in which it had dipped just 2 points or 0.1 percent. The Stock Exchange of... Read More
India, June 3 -- Quoin Pharmaceuticals, Ltd. (QNRX), a late clinical-stage pharmaceutical company, announced that it has submitted the Investigational New Drug application, or IND, for QRX003 to the U... Read More